A.3.4:5.2 - Biological editing

A CRISPR project says that an editing protocol changed a DNA target while keeping off-target risk under a bound. Result: identify the biological transformation from the continuing DNA referent, edit interval, boundary conditions, and sequence facts. Keep the protocol description, biochemical mechanism, lab U.Work, sequence measurement, risk evaluation, acceptance verdict, and publication separate. This sketch names neither a lab-work/transformation pair nor a matching predicate, so it asserts no connection between them; apply 4.2.4 only if that later claim is needed. For phrases such as edited sequence, lab output, or accepted result, name the exact participant and relation needed by the receiving claim.

Spontaneous non-agentive case — result: SeedlingFirstLeafUnfolding-B17 : U.Transformation is an actual first-leaf unfolding without an actor, method, or work claim. The continuing subject is the already existing Seedling-B17. Its boundary runs from unfolding onset t0 to the first stable full-expansion state t1; leaf-configuration and exposed-surface facts before, during, and after distinguish the episode under the stated growth conditions. The same-seedling rule permits ordinary cellular turnover and growth but excludes division, grafting, death, or replacement.

At this resolution the case asserts neither finer transformation parts nor partlessness. If a later use asks for an actor, apply A.3; if it asks for work, apply A.15.1 and then 4.2.4. Otherwise keep the case non-agentive and do not open A.15.PROD.